Schedule 13G ownership disclosure

QUOIN PHARMACEUTICALS LTD

American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share · CUSIP: 74907L409

Event date: 2026-01-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Ikarian Capital, LLC

    Shares: 211,538 · Class: 12.6%

  • Neil Shahrestani

    Shares: 211,538 · Class: 12.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-26-041438
Form type
SCHEDULE 13G/A
Filer
Ikarian Capital, LLC
CIK
CIK 1778253
Filed
Feb 06, 2026
Reporting period
Jan 31, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub